← Leaderboards
Henry Masur
Clinical Center
$938,316
Attributed
$1,901,323
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $675.4K · FY2015–17$1M$750K$500K$250K$0
'15
'16
'17
Funding mix
By agency
NIH$1,901,323 · 2
By mechanism
U01$1,901,323 · 2
Top collaborators
- Peter G Stock3 shared
- Steven Idell1 shared
- Christian J Woods1 shared
Others in their field
Top investigators on “United States National Institutes Of Health”
- Leonard Freedman · Leidos Biomedical Research, Inc.$816,847,401
- Sonia M Thomas · Research Triangle Institute$701,865,642
- David Heimbrook · Leidos Biomedical Research, Inc.$642,073,624
- Bambra Strokes · Ppd Development Lp$526,656,217
- Lawrence Corey · Fred Hutchinson Cancer Center$513,687,120
- Tracy L Nolen · Research Triangle Institute$474,487,152
Research focus
United States National Institutes Of HealthEnrollmentProtocols DocumentationHepatitis CPharmaceutical PreparationsHiv InfectionsNational Institute Of Allergy And Infectious DiseaseUniversitiesHepatitis C VirusHiv/HcvBaseClinical TrialsAcquired Immunodeficiency SyndromeSiteResearch PersonnelAffectInfectionComorbidityCollaborationsFundingSafetyDesignHuman SubjectWashington
Grant awards (100)
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities (SEARCH)$0
ZIA · FY2025 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2025 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2024 · CL · contact PI
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities (SEARCH)$0
ZIA · FY2024 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2024 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2023 · CL · contact PI
HIV Cardiac Risk Reduction and CD24Fc (CALIBER)$0
ZIA · FY2023 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2023 · CL · contact PI
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities (SEARCH)$0
ZIA · FY2023 · CL · contact PI
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities (SEARCH)$0
ZIA · FY2022 · CL · contact PI
HIV Cardiac Risk Reduction and CD24Fc (CALIBER)$0
ZIA · FY2022 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2022 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2022 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2021 · CL · contact PI
HIV Cardiac Risk Reduction and CD24Fc (CALIBER)$0
ZIA · FY2021 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2021 · CL · contact PI
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities (SEARCH)$0
ZIA · FY2021 · CL · contact PI
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities (SEARCH)$0
ZIA · FY2020 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2020 · CL · contact PI
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes after Hepatitis C Eradication (CHROME)$0
ZIA · FY2020 · CL · contact PI
HIV Cardiac Risk Reduction and CD24Fc (CALIBER)$0
ZIA · FY2020 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2020 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2019 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2019 · CL · contact PI
Reducing the Impact of Opioid Use Disorder on the Acquisition and Management of HIV and on Comorbidities$0
ZIA · FY2019 · CL · contact PI
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes after Hepatitis C Eradication (CHROME)$0
ZIA · FY2019 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2018 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2018 · CL · contact PI
Sofosbuvir/Ledipasvir for Hep C Rx in HIV/HCV Pre and Post Liver Transplant Subjects$0
ZIA · FY2018 · CL · contact PI
Cardiovascular Disease in HIV and Hepatitis C: Risk Outcomes after Hepatitis C Eradication (CHROME)$0
ZIA · FY2018 · CL · contact PI
Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant$621,488
U01 · FY2017 · AI
Sofosbuvir/Ledipasvir for Hep C Rx in HIV/HCV Pre and Post Liver Transplant Subjects$0
ZIA · FY2017 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2017 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2017 · CL · contact PI
Study Of Control Of Cytosolic Phospholipase A2 Activity$0
ZIA · FY2017 · CL · contact PI
Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant$604,473
U01 · FY2016 · AI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2016 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2016 · CL · contact PI
Study Of Control Of Cytosolic Phospholipase A2 Activity$0
ZIA · FY2016 · CL · contact PI
Sofosbuvir/Ledipasvir for Hep C Rx in HIV/HCV Pre and Post Liver Transplant Subjects$0
ZIA · FY2016 · CL · contact PI
Sofosbuvir and Ledipasvir in HIV/HCV Coinfected Pre and Post Liver Transplant$601,291
U01 · FY2015 · AI
Single chain urokinase plasminogen activator (scuPA) for treatment of loculated complicated parapneumonic effusions and empyema$74,071
U01 · FY2015 · HL
Study Of Control Of Cytosolic Phospholipase A2 Activity$0
ZIA · FY2015 · CL · contact PI
Sofosbuvir/Ledipasvir for Hep C Rx in HIV/HCV Pre and Post Liver Transplant Subjects$0
ZIA · FY2015 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2015 · CL · contact PI
Neurovascular MRI in the Assessment of HIV-Associated Neurocognitive Disorders$0
ZIA · FY2015 · CL · contact PI
Analysis of Stored Samples Collected Using Previously Expired Protocols$0
ZIA · FY2015 · CL · contact PI
Hemolysis, NO, and PAH in Malaria$0
ZIA · FY2015 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2014 · CL · contact PI
Study To Assess The Utility Of Oral Washes To Diagnose Pneumocystis Pneumonia$0
ZIA · FY2014 · CL · contact PI
Hemolysis, NO, and PAH in Malaria$0
ZIA · FY2014 · CL · contact PI
Study Of Control Of Cytosolic Phospholipase A2 Activity$0
ZIA · FY2014 · CL · contact PI
Hemolysis, NO, and PAH in Malaria$0
ZIA · FY2012 · CL · contact PI
Study To Assess The Utility Of Oral Washes To Diagnose Pneumocystis Pneumonia$0
ZIA · FY2012 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2012 · CL · contact PI
Study To Assess The Utility Of Oral Washes To Diagnose Pneumocystis Pneumonia$0
ZIA · FY2010 · CL · contact PI
Severe Acute Respiratory Syndrome$0
ZIA · FY2010 · CL · contact PI
DC Partnership for HIV/AIDS Progress (DC PFAP)$0
ZIA · FY2010 · CL · contact PI
Hemolysis, NO, and PAH in Malaria$0
ZIA · FY2010 · CL · contact PI
Study To Assess The Utility Of Oral Washes To Diagnose Pneumocystis Pneumonia$0
ZIA · FY2009 · CL · contact PI
Severe Acute Respiratory Syndrome$0
ZIA · FY2009 · CL · contact PI
Magnetic Resonance Imagery Study Of Avascular Necrosis Of The Hip In Asymptomati$0
ZIA · FY2009 · CL · contact PI
Evaluation of Endothelial Function in HIV Associated PAH$0
ZIA · FY2009 · CL · contact PI
Hemolysis, NO, and PAH in Malaria$0
ZIA · FY2009 · CL · contact PI
Severe Acute Respiratory Syndrome$0
Z01 · FY2008 · CL · contact PI
Study To Assess The Utility Of Oral Washes To Diagnose Pneumocystis Pneumonia$0
Z01 · FY2008 · CL · contact PI
Global initiative to characterize antiretroviral pharmacokinetics$0
Z01 · FY2008 · CL · contact PI
Magnetic Resonance Imagery Study Of Avascular Necrosis Of The Hip In Asymptomati$0
Z01 · FY2008 · CL · contact PI
Study To Assess The Utility Of Oral Washes To Diagnose P$0
Z01 · FY2006 · CL · contact PI
Endothelial Function in Normal Volunteers$0
Z01 · FY2006 · CL · contact PI
Severe Acute Respiratory Syndrome$0
Z01 · FY2006 · CL · contact PI
West Nile Disease$0
Z01 · FY2006 · CL · contact PI
Endothelial Dysfunction as a Risk Factor in HIV$0
Z01 · FY2006 · CL · contact PI
Endothelial Function in Normal Volunteers$0
Z01 · FY2005 · CL
Severe Acute Respiratory Syndrome$0
Z01 · FY2005 · CL
West Nile Disease$0
Z01 · FY2005 · CL
Endothelial Dysfunction as a Risk Factor in HIV$0
Z01 · FY2005 · CL
Magnetic Resonance Imagery Study Of Avascular Necrosis O$0
Z01 · FY2005 · CL
The Utility-Oral Washes-Diagnose Pneumocytis Pneumonia$0
Z01 · FY2005 · CL
Study To Assess The Utility Of Oral Washes To Diagnose P$0
Z01 · FY2004 · CL
Severe Acute Respiratory Syndrome$0
Z01 · FY2004 · CL
Endothelial Function in Normal Volunteers$0
Z01 · FY2004 · CL
West Nile Disease$0
Z01 · FY2004 · CL
Endothelial Dysfunction as a Risk Factor in HIV$0
Z01 · FY2004 · CL
Magnetic Resonance Imagery Study Of Avascular Necrosis O$0
Z01 · FY2004 · CL
Magnetic Resonance Imagery Study Of Avascular Necrosis O$0
Z01 · FY2003 · CL
Severe Acute Respiratory Syndrome$0
Z01 · FY2003 · CL
West Nile Disease$0
Z01 · FY2003 · CL
Endothelial Dysfunction as a Risk Factor in HIV$0
Z01 · FY2003 · CL
Study To Assess The Utility Of Oral Washes To Diagnose P$0
Z01 · FY2003 · CL
Study To Assess The Utility Of Oral Washes To Diagnose P$0
Z01 · FY2002 · CL
Magnetic Resonance Imagery Study Of Avascular Necrosis O$0
Z01 · FY2002 · CL
Study Of Salvage Regimens For Patients With Hiv Infectio$0
Z01 · FY2002 · CL
Magnetic Resonance Imagery Of Hip Avascular Necrosis$0
Z01 · FY2001 · CL
Study Of Salvage Regimens For Patients With Hiv$0
Z01 · FY2001 · CL
Study Of Antiretroviral Pharmacokinetics In Patients Fro$0
Z01 · FY2001 · CL
Study To Assess The Utility Of Oral Washes To Diagnose P$0
Z01 · FY2001 · CL
Magnetic Resonance Imagery Study of Avascular Necrosis of the Hip in Asymptomati$0
Z01 · FY2000 · CL
Study of Salvage Regimens for Patients with HIV Infection Demonstrating Virologi$0
Z01 · FY2000 · CL
Study to Assess the Utility of Oral Washes to Diagnose Pneumocystis Pneumonia$0
Z01 · FY2000 · CL